Hims & Hers to Acquire Australia's Eucalyptus in $1B Cash-Funded Expansion

Hims & Hers Health (HIMS) has identified Eucalyptus as its Australian acquisition target, a move set to significantly bolster its international footprint. The acquisition is expected to contribute approximately $450 million in annual revenue, driven by Eucalyptus's impressive triple-digit growth rate. This deal serves as a cornerstone of a broader $1 billion global expansion strategy aimed at diversifying the company's revenue streams and market presence. Management clarified that the $1 billion investment will be fully funded using existing cash reserves on the balance sheet, highlighting financial stability. Investor sentiment remained bullish following the news, as the acquisition underscores the company's aggressive scaling in the telehealth sector. Analysts believe the integration of a high-growth asset like Eucalyptus positions Hims & Hers for long-term dominance in the global digital health market.